Literature DB >> 16256229

Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?

Anke Petra Jellema1, Patricia Doornaert, Ben J Slotman, C Rene Leemans, Johannes A Langendijk.   

Abstract

BACKGROUND AND
PURPOSE: To investigate the association between the mean salivary gland and oral cavity dose, with patient-rated moderate and severe xerostomia and sticky saliva. PATIENTS AND METHODS: One hundred and fifty-seven patients treated with bilateral irradiation for head and neck cancer were included. The parotid and submandibular glands and the oral cavity were delineated on plannings-CT scans. At baseline and 6 and 12 months self-reported xerostomia and sticky saliva were assessed using the EORTC QLQ-H&N35 questionnaire.
RESULTS: At 6 months a significant association between the mean parotid (MD(par)) and mean submandibular dose (MD(subm)) and xerostomia was observed (OR - MD(par): 1.17; P=0.002 and OR - MD(subm): 1.08; P = 0.02). Between MD(par) and MD(subm), a significant interaction term was present. No significant association was found with the oral cavity dose. Xerostomia was reversible depending on MD(par) and MD(subm). Considering Sticky saliva, a significant association was found at 6 and 12 months with MD(subm) (OR: 1.03; P < 0.001). The P50 for sticky saliva increased with elapsing time.
CONCLUSIONS: Both MD(par) and MD(subm) influence the risk of xerostomia in irradiated patients at 6 months. This probability as a function of the mean parotid dose significantly depended on the mean dose in the submandibular glands. Sticky saliva mainly depends on MD(subm).

Entities:  

Mesh:

Year:  2005        PMID: 16256229     DOI: 10.1016/j.radonc.2005.10.002

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  27 in total

1.  The lessons of QUANTEC: recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome.

Authors:  Andrew Jackson; Lawrence B Marks; Søren M Bentzen; Avraham Eisbruch; Ellen D Yorke; Randal K Ten Haken; Louis S Constine; Joseph O Deasy
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

Review 2.  Radiotherapy dose-volume effects on salivary gland function.

Authors:  Joseph O Deasy; Vitali Moiseenko; Lawrence Marks; K S Clifford Chao; Jiho Nam; Avraham Eisbruch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

3.  Radiotherapy: IMRT reduces xerostomia and potentially improves QoL.

Authors:  Avraham Eisbruch
Journal:  Nat Rev Clin Oncol       Date:  2009-10       Impact factor: 66.675

4.  Parotid sparing and quality of life in long-term survivors of locally advanced head and neck cancer after intensity-modulated radiation therapy.

Authors:  Silke Tribius; Sven Haladyn; Henning Hanken; Chia-Jung Busch; Andreas Krüll; Cordula Petersen; Corinna Bergelt
Journal:  Strahlenther Onkol       Date:  2020-12-30       Impact factor: 3.621

Review 5.  Performance of the EORTC questionnaire for the assessment of quality of life in head and neck cancer patients EORTC QLQ-H&N35: a methodological review.

Authors:  Susanne Singer; Juan Ignacio Arraras; Wei-Chu Chie; Sheila E Fisher; Razvan Galalae; Eva Hammerlid; Ourania Nicolatou-Galitis; Claudia Schmalz; Irma Verdonck-de Leeuw; Eva Gamper; Judith Keszte; Dirk Hofmeister
Journal:  Qual Life Res       Date:  2012-11-28       Impact factor: 4.147

6.  Submandibular gland sparing in intensity-modulated radiotherapy for N0-stage nasopharyngeal carcinoma.

Authors:  L Huang; W Zhang; T Zhuang; F Wu; D Li; M Zheng; B Lin; M Zhuang; Z Chen
Journal:  Br J Radiol       Date:  2014-02-07       Impact factor: 3.039

7.  Reducing xerostomia after chemo-IMRT for head-and-neck cancer: beyond sparing the parotid glands.

Authors:  Michael Little; Matthew Schipper; Felix Y Feng; Karen Vineberg; Craig Cornwall; Carol-Anne Murdoch-Kinch; Avraham Eisbruch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-11-04       Impact factor: 7.038

8.  A Deep Learning Model for Predicting Xerostomia Due to Radiation Therapy for Head and Neck Squamous Cell Carcinoma in the RTOG 0522 Clinical Trial.

Authors:  Kuo Men; Huaizhi Geng; Haoyu Zhong; Yong Fan; Alexander Lin; Ying Xiao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-06-13       Impact factor: 7.038

9.  Dysphagia. Impact on quality of life after radio(chemo)therapy of head and neck cancer.

Authors:  Julia Maurer; Matthias Hipp; Christof Schäfer; Oliver Kölbl
Journal:  Strahlenther Onkol       Date:  2011-10-28       Impact factor: 3.621

10.  Sparing the region of the salivary gland containing stem cells preserves saliva production after radiotherapy for head and neck cancer.

Authors:  Peter van Luijk; Sarah Pringle; Joseph O Deasy; Vitali V Moiseenko; Hette Faber; Allan Hovan; Mirjam Baanstra; Hans P van der Laan; Roel G J Kierkels; Arjen van der Schaaf; Max J Witjes; Jacobus M Schippers; Sytze Brandenburg; Johannes A Langendijk; Jonn Wu; Robert P Coppes
Journal:  Sci Transl Med       Date:  2015-09-16       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.